UTRS (Minerva Surgical) 3-Year RORE % : 0.00% (As of Sep. 2023)


What is Minerva Surgical 3-Year RORE %?

Minerva Surgical UTRS -99.00% 3-Year RORE % is 0.00 as of Sep. 2023.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Minerva Surgical's 3-Year RORE % for the quarter that ended in Sep. 2023 was 0.00%.

The industry rank for Minerva Surgical's 3-Year RORE % or its related term are showing as below:

UTRS's 3-Year RORE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -4.23
* Ranked among companies with meaningful 3-Year RORE % only.

Minerva Surgical  (OTCPK:UTRS) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.

Minerva Surgical 3-Year RORE % Related Terms

Minerva Surgical 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical 3-Year RORE % Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
3-Year RORE %
0.00 0.00 0.00 16.94

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 16.94 -15.38 -41.55 -49.98

UTRS vs PAVM, ELUT, COCH: 3-Year RORE % Comparison

For the Medical Devices subindustry, Minerva Surgical's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minerva Surgical 3-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Minerva Surgical's 3-Year RORE % falls into.


Minerva Surgical 3-Year RORE % Calculation

Minerva Surgical's 3-Year RORE % for the quarter that ended in Sep. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -8.33--36.983 )/( -57.333-0 )
=28.653/-57.333
=-49.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2023 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 0.00 mean?
Minerva Surgical (UTRS) has a 3-Year RORE % of 0.00 as of Sep. 2023. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Minerva Surgical and its competitors.
Is Minerva Surgical's 3-Year RORE % too high?
Minerva Surgical's current 3-Year RORE % is 0.00.
How does Minerva Surgical's 3-Year RORE % compare to PAVM and ELUT?
Minerva Surgical's 3-Year RORE % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Minerva Surgical and its competitors. Minerva Surgical's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current 3-Year RORE % is 0.00 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.